Literature DB >> 10761538

Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group.

I K Wiklund1, L A Mattsson, R Lindgren, C Limoni.   

Abstract

A randomized, multicenter, double-blind, parallel group study was performed to assess the effects of a standardized ginseng extract compared with those of a placebo on quality of life (QoL) and on physiological parameters in symptomatic postmenopausal women. Validated questionnaires [Psychological General Well-Being (PGWB) index, Women's Health Questionnaire (WHQ)] and Visual Analogue (VA) scales were used to assess the effects of the extract on QoL at baseline and after 16 weeks' treatment with either the ginseng extract or placebo. To assess the efficacy of ginseng on postmenopausal symptoms, physiological parameters [follicle-stimulating hormone (FSH) and estradiol levels, endometrial thickness, maturity index and vaginal pH] were recorded at the same time points. Of the 384 randomized patients (mean age 53.5 +/- 4.0 years), the questionnaires were completed by 193 women treated with ginseng and 191 treated with placebo. With regard to the primary endpoint (total score of the PGWB index) the extract showed only a tendency for a slightly better overall symptomatic relief (p < 0.1). Exploratory analysis of PGWB subsets, however, reported p-values < 0.05 for depression, well-being and health subscales in favor of ginseng compared with placebo. No statistically significant effects were seen for the WHQ and the VA scales or the physiological parameters, including vasomotor symptoms (hot flushes). The positive effects of ginseng on health-related QoL in menopausal women should be further investigated. This study shows, however, that the beneficial effects of ginseng are most likely not mediated by hormone replacement-like effects, as physiological parameters such as FSH and estradiol levels, endometrial thickness, maturity index and vaginal pH were not affected by the treatment.

Entities:  

Mesh:

Year:  1999        PMID: 10761538

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Res        ISSN: 0251-1649


  24 in total

1.  Complementary and alternative medicine for the treatment of multiple sclerosis.

Authors:  Vijayshree Yadav; Lynne Shinto; Dennis Bourdette
Journal:  Expert Rev Clin Immunol       Date:  2010-05       Impact factor: 4.473

2.  Antidepressant Effects of the Ginsenoside Metabolite Compound K, Assessed by Behavioral Despair Test and Chronic Unpredictable Mild Stress Model.

Authors:  Wu Song; Yan Guo; Shuang Jiang; Lin Wei; Zhi Liu; Xiaoyan Wang; Ying Su
Journal:  Neurochem Res       Date:  2018-05-22       Impact factor: 3.996

Review 3.  Botanical and dietary supplements for menopausal symptoms: what works, what does not.

Authors:  Stacie E Geller; Laura Studee
Journal:  J Womens Health (Larchmt)       Date:  2005-09       Impact factor: 2.681

Review 4.  Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance.

Authors:  K Simon Yeung; Marisol Hernandez; Jun J Mao; Ingrid Haviland; Jyothirmai Gubili
Journal:  Phytother Res       Date:  2018-02-21       Impact factor: 5.878

Review 5.  Contemporary alternatives to plant estrogens for menopause.

Authors:  Stacie E Geller; Laura Studee
Journal:  Maturitas       Date:  2006-08-01       Impact factor: 4.342

Review 6.  Complementary and alternative medicine in the treatment of menopausal symptoms.

Authors:  Chong Shou; Justin Li; Zitao Liu
Journal:  Chin J Integr Med       Date:  2011-12-03       Impact factor: 1.978

7.  Identification of antidepressant-like ingredients in ginseng root (Panax ginseng C.A. Meyer) using a menopausal depressive-like state in female mice: participation of 5-HT2A receptors.

Authors:  Noriko Yamada; Hiroaki Araki; Hiroyuki Yoshimura
Journal:  Psychopharmacology (Berl)       Date:  2011-03-22       Impact factor: 4.530

Review 8.  Panax ginseng: a systematic review of adverse effects and drug interactions.

Authors:  Joanna Thompson Coon; Edzard Ernst
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

9.  Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions.

Authors:  Deirdre R Pachman; Jason M Jones; Charles L Loprinzi
Journal:  Int J Womens Health       Date:  2010-08-09

10.  Study designs of randomized controlled trials not based on Chinese medicine theory are improper.

Authors:  Jian Yan; Veronica F Engle; Yuxin He; Yan Jiao; Weikuan Gu
Journal:  Chin Med       Date:  2009-02-25       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.